Somnigroup International (SGI)

NYSE Consumer Discretionary Home Furnishings S&P MidCap 400
$64.17
-3.70 (-5.45%)
Close of Nov 06, 2026 · end-of-day data
SMA 50SMA 2005Y/10Y use weekly candles (10/40-week averages)

Performance

price return
1W+1.0%
1M+2.9%
3M-1.0%
6M-7.4%
YTD-28.1%
1Y-19.4%
3Y+58.8%
5Y+44.3%

Key statistics

Full financials →
Market cap$13.5B
P/E (TTM)25.6
EPS (TTM, diluted)$2.51
P/S1.77
P/B4.18
EV / EBITDA14.2
Revenue (TTM)$7.62B
Revenue growth+27.1%
Net margin7.0%
ROE16.5%
Debt / equity1.37
FCF yield5.7%
Dividend yield1.03%
Payout ratio26%
Beta (1Y)1.37
Volatility (1Y)42.8%
52-week range$60.08 – $98.56
Avg volume (50D)3.22M

Revenue & net income — last 8 quarters

Statements →

Chart pattern: Descending Channel (weekly)

Forming
SGI Descending Channel chart

Trigger $58.49 (-8.9% away). Details →

Aug 26, 12:41 PM ET

Somnigroup Completes $2.3 Billion Leggett & Platt Acquisition

Mixed m&a Written later 2.012.037.01

Somnigroup completed its all-stock acquisition of Leggett & Platt on August 26, 2026, a transaction the company values at about $2.3 billion including Leggett & Platt's existing debt. Former Leggett & Platt shareholders now own about 9% of the combined company on a fully diluted basis, which dilutes existing Somnigroup holders, while the company reports leverage reduced by about 0.2 times and a higher synergy target.

  • Merger closed August 26, 2026 under an agreement dated April 13, 2026; Leggett & Platt is now a wholly owned subsidiary.
  • Each Leggett & Platt share converted into 0.1455 Somnigroup shares; former Leggett & Platt shareholders own about 9% of the combined company.
  • Annual run-rate synergy target raised to $75 million from the initial $50 million; net leverage reduced by about 0.2 times.
  • The company expects about $50 million of annualized non-cash expense from fair value adjustments to the acquired business and about $10 million from the acquired bonds; $1.5 billion of Leggett & Platt notes remain outstanding.
Read the filing on SEC.gov ↗
Aug 6, 6:37 AM ET

Somnigroup Q2 net sales fall 3.0%; adjusted EPS rises 9.4% to $0.58

Mixed earnings Written later 2.028.01

Somnigroup reported second-quarter 2026 net sales down 3.0% to $1.82 billion, while diluted EPS rose 10.6% to $0.52 and adjusted EPS rose 9.4% to $0.58. The company also revised its full-year 2026 adjusted EPS outlook to a range of $2.85 to $3.15, and declared a $0.17 quarterly dividend, so shareholders see weaker sales alongside higher earnings and a changed forecast.

  • Q2 2026 net sales decreased 3.0% to $1,823.5 million from $1,880.8 million a year earlier; Mattress Firm net sales fell 2.8%, mainly from store closures
  • Q2 2026 diluted EPS rose 10.6% to $0.52; adjusted EPS rose 9.4% to $0.58; net income rose 12.0% to $110.9 million
  • Full-year 2026 adjusted EPS guidance revised to $2.85 to $3.15, about an 11% increase from 2025 adjusted EPS at the midpoint
  • Quarterly cash dividend of $0.17 per share, payable September 3, 2026, to holders of record on August 20, 2026
Read the filing on SEC.gov ↗
Jul 27, 4:05 PM ET

Somnigroup refinances $2.9 billion credit facilities, extends maturities to 2031

Neutral financing Written later 1.012.037.01

On July 27, 2026, Somnigroup entered into Amendment No. 5 to its 2023 Credit Agreement, providing a $1.2 billion term loan A and a $510 million incremental revolving commitment, with the revolver totaling $1.7 billion after the amendment. The company used $700 million to prepay part of its 2025 Term B loans and said the refinancing reduces expected annual interest expense by approximately $5 million, while the amendment also adjusts terms tied to its anticipated acquisition of Leggett & Platt.

  • Term loan A of $1.2 billion and revolving credit facility of $1.7 billion both mature July 27, 2031
  • $700 million prepayment of outstanding 2025 Refinancing Term B Loans
  • Company expects approximately $5 million lower annual interest expense
  • Amendment modifies terms for the anticipated Leggett & Platt, Incorporated acquisition and allows collateral release upon an Investment Grade Rating
Read the filing on SEC.gov ↗
May 7, 6:38 AM ET

Somnigroup Q1 net sales rise 12% to $1.8 billion; adjusted EPS up 20%

Positive earnings Written later 2.028.01

Somnigroup reported first quarter 2026 net sales of $1,801.5 million, up 12.3%, mainly because Mattress Firm was included for a full quarter. Diluted EPS was $0.49, compared with a loss of $(0.17) a year earlier, and adjusted EPS rose 20.4% to $0.59. The company reaffirmed its 2026 adjusted EPS guidance of $3.00 to $3.40, which it said is about a 19% increase at the midpoint over 2025.

  • Net sales rose 12.3% to $1,801.5 million from $1,604.7 million; Mattress Firm contributed a full quarter versus February 5 to March 31 in 2025.
  • Diluted EPS was $0.49 versus a loss of $(0.17); adjusted EPS rose 20.4% to $0.59.
  • Mattress Firm adjusted gross margin declined 360 basis points to 31.5%, which the company attributed to promotional spending, product mix and fixed cost deleverage.
  • The board declared a quarterly cash dividend of $0.17 per share, payable June 4, 2026, to holders of record on May 21, 2026.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Recent SEC filings

EDGAR ↗

Famous investors who own SGI

All investors →
InvestorValue% of portfolioLast quarter
Dan Loeb Third Point $201.55M4.31% Added
George Soros Soros Fund Management $1.06M0.01% Reduced
Ray Dalio Bridgewater Associates $473.22K0.00% New

From each investor's latest 13F filing (Q2 2026); positions are as of the quarter end and filed up to 45 days later.

Trades disclosed by members of Congress

All SGI congressional trades →
TradedMemberTypeAmount
Aug 25, 2026April McClain Delaney MD-06Sell$100,001 – $250,000
Jul 30, 2026April McClain Delaney MD-06Buy$15,001 – $50,000
Mar 31, 2026April McClain Delaney MD-06Buy$1,001 – $15,000
Mar 16, 2026April McClain Delaney MD-06Buy$1,001 – $15,000
Mar 13, 2026April McClain Delaney MD-06Buy$1,001 – $15,000
Mar 09, 2026April McClain Delaney MD-06Buy$1,001 – $15,000
Feb 09, 2026April McClain Delaney MD-06Sell (partial)$1,001 – $15,000
Jan 22, 2026April McClain Delaney MD-06Sell (partial)$1,001 – $15,000

From House periodic transaction reports (STOCK Act); amounts are the form's ranges.

Prices are end-of-day and split-adjusted. Financial data from Somnigroup International's SEC XBRL filings. Not investment advice.